Jeff Buel

From SourceWatch
Jump to navigation Jump to search
ALECexposed-80px.png

Learn more about corporations VOTING to rewrite our laws.

Jeff Buel is the Director of State Government Affairs at Johnson & Johnson)[1]

Buel represents Johnson & Johnson at Pharmaceutical Research and Manufacturers of America (PhRMA), the pharmaceutical industry's chief trade association, as New Mexico chair and Arizona vice chair. He lobbies for Johnson & Johnson in Arizona, Idaho, New Mexico and Utah.[2]

Ties to American Legislative Exchange Council

Buel is on the Executive Committee of the American Legislative Exchange Council (ALEC) Health and Human Services Task Force as of 2011.[3] He has represented pharmaceutical interests at ALEC since 2005.[4]

About ALEC
ALEC is a corporate bill mill. It is not just a lobby or a front group; it is much more powerful than that. Through ALEC, corporations hand state legislators their wishlists to benefit their bottom line. Corporations fund almost all of ALEC's operations. They pay for a seat on ALEC task forces where corporate lobbyists and special interest reps vote with elected officials to approve “model” bills. Learn more at the Center for Media and Democracy's ALECexposed.org, and check out breaking news on our PRWatch.org site.

Background

Buel worked for Bristol-Myers Squibb and AstraZeneca before joining Johnson & Johnson in 2000.[5]

Articles and resources

Related SourceWatch articles

External resources

External articles

References

  1. American Legislative Exchange Council Private Sector Executive Committee, organization website, accessed June 2, 2011
  2. American Legislative Exchange Council Jeff A. Buel, organizational bio, accessed June 2, 2011
  3. American Legislative Exchange Council Private Sector Executive Committee, organization website, accessed June 2, 2011
  4. Jeff Buel Profile, "LinkedIn", accessed July, 2011
  5. American Legislative Exchange Council Jeff A. Buel, organizational bio, accessed June 2, 2011
This article is a stub. You can help by expanding it.